Pexa-Vec (JX-594) is a thymidine kinase gene-inactivated vaccinia virus engineered by expressing the transgenes, including GM-CSF and β-galactosidase; it selectively targets tumor cells with activation of the Ras/MAPK signaling pathway [35,39]. The gene discussed is CSF2; the disease is neoplasm.